Amy L. Burroughs Terns Pharmaceuticals, Inc. (TERN) insider trading activity
Amy L. Burroughs is Chief Executive Officer of Terns Pharmaceuticals, Inc.. Currently has a direct ownership of 288,976 shares of TERN, which is worth approximately $6.5 Million. The most recent transaction as insider was on Jan 15, 2026, when has been sold 68,749 shares (Common Stock) at a price of $37.28 per share, resulting in proceeds of $2,562,962. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
289K
513.76%
3M change
1413.04%
12M change
Total Value Held
$6.5 Million
Amy L. Burroughs Transaction History
Also insider at
ALB
Amy L. Burroughs
Chief Executive Officer
Minneapolis, MN